EVO is a deep-tech bioengineering company.
EVO has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
EVO's investors include Uni.Fund.
EVO is headquartered in Athens, Greece.
EVO is a deep-tech bioengineering company.
EVO is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EVO — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/evo-athens. Accessed October 22, 2026.
VCBacked. (2024). EVO — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/evo-athens
{{cite web |title=EVO — Funding & Investors |url=https://www.vcbacked.co/company/evo-athens |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated